We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
2 watching
Current Price
$0
$-0.01
(-0.66%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
109.96M
52-Week High
12.66
52-Week Low
1.445
Average Volume
0.02M
Dividend Yield
--
P/E Ratio
--
Market Capitalization109.96M
52-Week High12.66
52-Week Low1.445
Average Volume0.02M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Read More
News & Events about Stockal+Disclaimer.pdf.
Globe Newswire
6days ago
TOI continues expansion in South FloridaCERRITOS, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced its entrance into Miami-Dade County, Florida with the acquisition of ...
Zolmax
24days ago
The Oncology Institute, Inc. (NASDAQ:TOI Get Rating) major shareholder Havencrest Healthcare Partners sold 58,500 shares of the companys stock in a transaction on Wednesday, November 2nd. The stock was sold at an average price of $3.94, for a total transaction of $230,490.00. Following the ...
Ticker Report
1month ago
The Oncology Institute, Inc. (NASDAQ:TOI Get Rating) major shareholder Havencrest Healthcare Partners sold 16,765 shares of the stock in a transaction that occurred on Monday, October 3rd. The stock was sold at an average price of $4.72, for a total transaction of $79,130.80. Following the ...
Zolmax
1month ago
The Oncology Institute, Inc. (NASDAQ:TOI Get Rating) major shareholder Havencrest Healthcare Partners sold 11,000 shares of the stock in a transaction that occurred on Friday, September 30th. The stock was sold at an average price of $4.68, for a total value of $51,480.00. Following the transaction...
Ticker Report
2 months ago
The Oncology Institute, Inc. (NASDAQ:TOI Get Rating) major shareholder Havencrest Healthcare Partners sold 19,629 shares of the businesss stock in a transaction on Monday, September 19th. The stock was sold at an average price of $4.33, for a total transaction of $84,993.57. Following...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.01
(-0.66%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00